首页> 外文期刊>Japanese Journal of Pharmacology >Role of glutathione in stabilization of nitric oxide during hypertension developed by inhibition of nitric oxide synthase in the rat.
【24h】

Role of glutathione in stabilization of nitric oxide during hypertension developed by inhibition of nitric oxide synthase in the rat.

机译:谷胱甘肽在高血压中一氧化氮稳定中的作用是通过抑制大鼠中一氧化氮合酶而产生的。

获取原文
获取原文并翻译 | 示例
           

摘要

The present study examined the role of glutathione in the development of hypertension induced by long-term inhibition of nitric oxide (NO)-synthase. Three groups of rats were investigated: control group, L-NAME group: group with NO-synthase inhibition by N(G)-nitro-L-arginine methyl ester (L-NAME, 40 mg/kg per day) for 2 weeks, and BSO group: group with glutathione synthesis inhibitor L-buthionine sulfoximine (BSO, 1.4 mmol/kg per 12 h) for 3 days. All the groups were subjected to an acute i.v. experiment in which the given substances were exchanged between groups. There was no change in systolic blood pressure (SBP) in the control group after 1 and 2 h of acute BSO (1.4 mmol/kg, i.v.) treatment. In the L-NAME group, SBP increased significantly by 10% after 2 h of acute BSO treatment. In the BSO group, SBP did not change vs control; however, after 2 h of acute L-NAME (10 mg/kg, i.v.) treatment, the increase in SBP exceeded by 12% (P<0.05) that of the control group. Along with the increase in SBP, acute BSO treatment significantly potentiated the decrease in plasma nitriteitrate concentration in the L-NAME group. The acute BSO-induced glutathione decrease was significantly greater in the L-NAME group than in the control group. In NO-deficient hypertensive rats, the results are indicative of a decrease in glutathione synthesis and a stabilizing role of glutathione.
机译:本研究探讨了谷胱甘肽在长期抑制一氧化氮(NO)合酶诱导的高血压发展中的作用。研究了三组大鼠:对照组,L-NAME组:用N(G)-硝基-L-精氨酸甲酯(L-NAME,每天40 mg / kg)抑制NO合酶2周, BSO组:谷胱甘肽合成抑制剂L-丁硫氨酸亚砜亚胺(BSO,每12小时1.4 mmol / kg)治疗3天。所有组均接受急性静脉内注射。实验是在组之间交换给定的物质。急性BSO(1.4 mmol / kg,i.v.)治疗1和2小时后,对照组的收缩压(SBP)没有变化。在L-NAME组中,急性BSO治疗2小时后,SBP明显增加了10%。在BSO组中,SBP与对照相比无变化。但是,急性L-NAME(10 mg / kg,静脉内)治疗2小时后,SBP的增加超过了对照组的12%(P <0.05)。随着SBP的增加,急性BSO治疗显着增强了L-NAME组血浆亚硝酸盐/硝酸盐浓度的降低。 L-NAME组的BSO诱导的急性谷胱甘肽减少明显比对照组更大。在NO缺乏型高血压大鼠中,该结果表明谷胱甘肽合成减少并且谷胱甘肽具有稳定作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号